findmyKOL
Clinical trialNCT04536051UnknownPhase 3Interventional

A Study of a Candidate COVID-19 Vaccine (COV003)

SponsorUniversity of OxfordEnrollment10,300Coronavirus
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A Randomized, Controlled, Phase III Study to Determine the Safety, Efficacy, and Immunogenicity of the Non-Replicating ChAdOx1 nCoV-19 Vaccine.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Brazil
  • Instituto D'Or de Pesquisa E Ensino - I'Dor

    Salvador, Estado de Bahia, Brazil

    Ana Verena Mendes
    Recruiting
  • Centro de Pesquisas Clinicas de Natal (cpclin)

    Natal, Rio Grande do Norte, Brazil

    Eveline Pipolo Milan
    Recruiting
  • Hospital Das Clinicas de Porto Alegre

    Porto Alegre, Rio Grande do Sul, Brazil

    Eduardo Sprinz
    Recruiting
  • Universidade Federal de Santa Maria (ufsm)

    Santa Maria, Rio Grande do Sul, Brazil

    Alexandre Vargas Schwarzbold
    Recruiting
  • Instituto D'Or de Pesquisa E Ensino - I'Dor

    Rio de Janeiro, Brazil

    Ana Maria Pitella de Souze Leite
    Recruiting
  • Crie, Universidade Federal de São Paulo

    São Paulo, Brazil

    Lily Weckx
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

ChAdOx1 nCoV-19 single dose + paracetamolChAdOx1 nCoV-19 two dose + paracetamolMenACWY prime & saline placebo boost + paracetamolMenACWY single dose + paracetamol
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Jun 2020
Primary completion
30 Sept 2021
Completion
30 Sept 2021
Last update posted
27 Nov 2020
Registered enrollment
10,300
Registry id
NCT04536051
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.